An authorized generic of Cosmegen was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (dactinomycin) is available.
Source: FDA, updated October 30, 2026
Generic name: dactinomycin
Used for: Wilms tumor (a kidney cancer) · Rhabdomyosarcoma (a soft-tissue cancer) · Ewing sarcoma · Testicular cancer that has spread · Gestational trophoblastic neoplasia (a pregnancy tumor) · Solid tumors in one area, including ones that came back · 5 more
Ask for the cash price
Generic dactinomycin
No pharmacy we check posts a price for it.
A regular generic has the same active ingredient as Cosmegen, and the FDA requires it to work the same way.
Details for each option
Cosmegen itself isn’t sold as a prescription anymore. Its generic versions, if any, are in the other tabs.
An authorized generic of Cosmegen was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (dactinomycin) is available.
Source: FDA, updated October 30, 2026
4 companies sell a generic of Cosmegen that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
It’s mostly filled by specialty pharmacies. Your prescriber’s office or insurer can tell you which one to use.
0.5 mg/mL
| Package | NDC |
|---|---|
| Carton of 1 mL | 55150-431-01 |
0.5 mg/mL
| Package | NDC |
|---|---|
| Carton of 1 mL | 55150-928-02 |
Inactive ingredients: mannitol
0.5 mg
| Package | NDC |
|---|---|
| Carton of 1 | 42658-008-01 |
Inactive ingredients: mannitol
Product page on meithealpharma.com
0.5 mg/mL
| Package | NDC |
|---|---|
| Carton of 1 mL | 71288-129-02 |
Inactive ingredients: mannitol, water
Product page on xgenpharmadjb.com
0.5 mg/mL
| Package | NDC |
|---|---|
| Carton of 1 mL | 39822-2100-2 |
Inactive ingredients: mannitol
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
Wilms Tumor
COSMEGEN is indicated for the treatment of adult and pediatric patients with Wilms tumor, as part of a multi-phase, combination chemotherapy regimen.
Rhabdomyosarcoma
COSMEGEN is indicated for the treatment of adult and pediatric patients with rhabdomyosarcoma, as part of a multi-phase, combination chemotherapy regimen.
Ewing Sarcoma
COSMEGEN is indicated for the treatment of adult and pediatric patients with Ewing sarcoma, as part of a multi-phase, combination chemotherapy regimen.
Metastatic Nonseminomatous Testicular Cancer
COSMEGEN is indicated for the treatment of adult and pediatric patients with metastatic, nonseminomatous testicular cancer, as part of a multi-phase, combination chemotherapy regimen.
Gestational Trophoblastic Neoplasia
COSMEGEN is indicated for the treatment of post-menarchal patients with gestational trophoblastic neoplasia, as a single agent or as part of a combination chemotherapy regimen.
Regional Perfusion in Locally Recurrent and Locoregional Solid Malignancies
COSMEGEN is indicated for the treatment of adult patients with locally recurrent or locoregional solid malignancies, as a component of palliative or adjunctive regional perfusion.
Source: the FDA label for Cosmegen (Recordati Rare), August 15, 2018. Full label from the FDA (PDF)
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/cosmegen/